JP2012504589A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012504589A5 JP2012504589A5 JP2011529634A JP2011529634A JP2012504589A5 JP 2012504589 A5 JP2012504589 A5 JP 2012504589A5 JP 2011529634 A JP2011529634 A JP 2011529634A JP 2011529634 A JP2011529634 A JP 2011529634A JP 2012504589 A5 JP2012504589 A5 JP 2012504589A5
- Authority
- JP
- Japan
- Prior art keywords
- anthrax
- range
- vaccine according
- anthrax vaccine
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000193738 Bacillus anthracis Species 0.000 claims 21
- 229960005486 vaccine Drugs 0.000 claims 20
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims 7
- 101710194807 Protective antigen Proteins 0.000 claims 5
- 239000002671 adjuvant Substances 0.000 claims 2
- 229940037003 alum Drugs 0.000 claims 2
- 229960002235 anthrax antigen Drugs 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19496708P | 2008-10-02 | 2008-10-02 | |
| US61/194,967 | 2008-10-02 | ||
| PCT/GB2009/051293 WO2010038076A1 (en) | 2008-10-02 | 2009-10-02 | Anthrax vaccine formulation and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012504589A JP2012504589A (ja) | 2012-02-23 |
| JP2012504589A5 true JP2012504589A5 (enExample) | 2012-11-22 |
| JP5701760B2 JP5701760B2 (ja) | 2015-04-15 |
Family
ID=41292568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011529634A Expired - Fee Related JP5701760B2 (ja) | 2008-10-02 | 2009-10-02 | 炭疽菌ワクチン製剤とその用途 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9616117B2 (enExample) |
| EP (1) | EP2344188B1 (enExample) |
| JP (1) | JP5701760B2 (enExample) |
| AU (1) | AU2009299615B2 (enExample) |
| CA (1) | CA2738621C (enExample) |
| IL (1) | IL212118A (enExample) |
| WO (1) | WO2010038076A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2738621C (en) | 2008-10-02 | 2017-01-31 | Pharmathene Inc. | Anthrax vaccine formulation and uses thereof |
| WO2014134187A1 (en) * | 2013-02-26 | 2014-09-04 | The Regents Of The University Of California | Compositions and methods for the treatment of cancer |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK140815B (da) | 1975-06-10 | 1979-11-19 | Weeke Bengt | Fremgangsmåde til påvisning eller bestemmelse af antistoffer i legemsvæsker ved hjælp af kendte antigener eller til bestemmelse af antigener ved hjælp af kendte antistoffer fra legemsvæsker samt et middel til anvendelse ved udøvelse af fremgangsmåden. |
| DE2632478A1 (de) | 1975-07-23 | 1977-02-24 | Coulter Electronics | Verfahren zur erfassung und trennung von antigenen und antikoerperchen im blut und in anderen proben |
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| JPH0779694B2 (ja) | 1985-07-09 | 1995-08-30 | カドラント バイオリソ−シズ リミテツド | 蛋白質および同類品の保護 |
| US5690942A (en) | 1995-06-02 | 1997-11-25 | American Home Products Corporation | Adjuvants for viral vaccines |
| US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| GB9618107D0 (en) | 1996-08-30 | 1996-10-09 | Secr Defence | Vaccine production |
| US20020120228A1 (en) | 2000-06-08 | 2002-08-29 | Yuh-Fun Maa | Powder compositions |
| CA2412197A1 (en) | 2000-06-08 | 2001-12-13 | Powderject Vaccines, Inc. | Powder compositions |
| GB0016702D0 (en) | 2000-07-08 | 2000-08-23 | Secr Defence Brit | Expression system |
| WO2002100340A2 (en) | 2001-06-08 | 2002-12-19 | Avant Immunotherapeutics, Inc. | Improved vaccination against anthrax |
| GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| GB0126266D0 (en) | 2001-11-01 | 2002-01-02 | Microbiological Res Authority | Anthrax antigenic compositions |
| UA80809C2 (en) | 2001-11-05 | 2007-11-12 | Process for preparation of protective antigen protein of anthracis with e.coli | |
| MXPA04005538A (es) | 2001-12-05 | 2005-06-08 | Bhatnagar Rakesh | Procedimiento para la preparacion de una vacuna no toxica contra el antrax. |
| WO2005123131A2 (en) | 2004-06-14 | 2005-12-29 | Medimmune Vaccines, Inc. | High pressure spray-dry of bioactive materials |
| WO2004073735A1 (en) | 2003-02-13 | 2004-09-02 | Becton, Dickinson And Company | Improved anthrax vaccines and delivery methods |
| US7355027B2 (en) | 2004-06-16 | 2008-04-08 | Dynport Vaccine Company Llc | Bacillus anthracis protective antigen |
| KR20070057954A (ko) | 2004-09-28 | 2007-06-07 | 알자 코포레이션 | 알룸-애주번트가 있는 면역 활성제의 안정화 |
| GB0525213D0 (en) | 2005-12-12 | 2006-01-18 | Secr Defence | Vaccine |
| WO2008048344A2 (en) | 2006-02-13 | 2008-04-24 | Fraunhofer Usa, Inc. | Bacillus anthracis antigens, vaccine compositions, and related methods |
| GB0607462D0 (en) | 2006-04-13 | 2006-05-24 | Avecia Ltd | Assay |
| WO2008079464A2 (en) | 2006-09-08 | 2008-07-03 | Becton, Dickinson And Company | Stable powder formulations of alum-adsorbed vaccines |
| EP1972347A1 (en) | 2007-03-19 | 2008-09-24 | Becton, Dickinson and Company, Wagner, Jaconda | Stable vaccine powder formulations |
| WO2008152654A1 (en) | 2007-06-11 | 2008-12-18 | Panacea Biotec Limited | Anthrax fusion proteins, compositions and uses thereof |
| GB0801122D0 (en) * | 2008-01-22 | 2008-02-27 | Avecia Biolog Ltd | Vaccine composition |
| CA2738621C (en) | 2008-10-02 | 2017-01-31 | Pharmathene Inc. | Anthrax vaccine formulation and uses thereof |
| CA2750321A1 (en) | 2009-01-22 | 2010-07-29 | Pharmathene, Inc. | Stable vaccine compositions and methods of use |
-
2009
- 2009-10-02 CA CA2738621A patent/CA2738621C/en active Active
- 2009-10-02 WO PCT/GB2009/051293 patent/WO2010038076A1/en not_active Ceased
- 2009-10-02 JP JP2011529634A patent/JP5701760B2/ja not_active Expired - Fee Related
- 2009-10-02 EP EP09785720.5A patent/EP2344188B1/en not_active Not-in-force
- 2009-10-02 AU AU2009299615A patent/AU2009299615B2/en not_active Ceased
- 2009-10-02 US US12/998,245 patent/US9616117B2/en not_active Expired - Fee Related
-
2011
- 2011-04-04 IL IL212118A patent/IL212118A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007095976A3 (de) | Adjuvanz in form einer lipid-modifizierten nukleinsäure | |
| JP2014051497A5 (enExample) | ||
| JP2016513638A5 (enExample) | ||
| JP2013509429A5 (enExample) | ||
| JP2010529999A5 (enExample) | ||
| JP2016040284A5 (enExample) | ||
| JP2013520405A5 (enExample) | ||
| JP2011250797A5 (enExample) | ||
| JP2011522816A5 (enExample) | ||
| EP1708749A4 (en) | BACTERIAL FLAGELLINS CONTAINING VACCINE ADJUVANTIES FOR MUCOSAL USE AS ACTIVE COMPONENTS | |
| JP2013534248A5 (enExample) | ||
| NZ624059A (en) | Therapeutic applications of activation of human antigen-presenting cells through dectin-1 | |
| MX360448B (es) | Adyuvantes sinteticos de glucopiranosil-lipido. | |
| WO2009095226A3 (en) | NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS | |
| JP2014521735A5 (enExample) | ||
| MX2010004482A (es) | Anticuerpos anti-proteina g vsr. | |
| WO2009060281A3 (en) | Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties | |
| MA32633B1 (fr) | Formes cristallines d'un derive 2-thiazolyl-4-quinolinyl-oxy, un inhibiteur puissant du vhc | |
| JP2013519645A5 (enExample) | ||
| JP2013501007A5 (enExample) | ||
| JP2014503593A5 (enExample) | ||
| JP2013510169A5 (enExample) | ||
| WO2011094357A8 (en) | Respiratory virus epitopes templated into double stranded coiled -coils and use thereof in immunization | |
| NZ593524A (en) | A nonapeptide with anti-tumour activity | |
| JP2015509075A5 (enExample) |